Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PLSIA (Premier Laser Systems) -- Ignore unavailable to you. Want to Upgrade?

To: Westergaard who wrote (1673)	10/22/1998 10:50:00 PM
From: Pluvia	Respond to of 1773

<<<I'm on record as predicting an opening between 2-3 and a close 5-6. Hmmm..... It's a reach, I admit.>>> Well so far your record is about equal to your stock picking record - it stinks. What could anoyone expect from a guy that steals money from starving African children. Cheers Steve

To: Westergaard who wrote (1673)	10/24/1998 1:34:00 PM
From: jackie	Read Replies (1) \| Respond to of 1773

Closed at 3 21/32, up 17%. Opened at 3 5/16. Hadn't checked on this company in some time. Interesting to see they have received approval for the treatment of children with the Centauri laser system. It would appear what ever legal difficulties the company got itself into, they are behind them. Otherwise, why would the NASDAQ allow this to trade again? I don't have all the facts, but I'm inclined to believe the management is guilty more of poor judgement than intent to defraud. When you get into the area of when to count sales on the books, that is really wide open to any interpretation you wish. I also think most of the real difficulties were caused by Schein. Whether it was an honest misunderstanding, or Schein was backing down from a verbal agreement, it was clear Premier thought they had an agreement and proceeded accordingly. It is nice to see they are going to do their own sales in the future. One of the sad things about all medical companies is this tremendous barrier erected by the FDA and insurance industry. It takes years to get the FDA to approve something and more years for the insurance guys to start paying for it. One has to wonder how many lives are lost every year, or pain suffered, because of these delays in acceptance for innovative products and concepts. We have spent years of training, research, and clinical practice and it gets lost in bureaucracy. Sad. I wish the company the very best. I also think they are going to do very well. Regards, Jack Simmons